Cargando…

A Novel Panel of Serum Biomarkers for MPM Diagnosis

Exposure to asbestos is the main cause of malignant pleural mesothelioma (MPM), a highly aggressive cancer of the pleura. Since the only tools for early detection are based on radiological tests, some authors focused on serum markers (i.e., mesothelin). The aim of this study was the evaluation of ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonotti, A., Foddis, R., Landi, S., Melaiu, O., De Santi, C., Giusti, L., Donadio, E., Ciregia, F., Mazzoni, M. R., Lucacchini, A., Bovenzi, M., Comar, M., Pantani, E., Pistelli, A., Cristaudo, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350384/ https://www.ncbi.nlm.nih.gov/pubmed/28348450 http://dx.doi.org/10.1155/2017/3510984

Ejemplares similares

Comparative proteomic analysis of malignant pleural mesothelioma: Focusing on the biphasic subtype
por: Giusti, Laura, et al.
Publicado: (2016)

Role of Prosaposin and Extracellular Sulfatase Sulf-1 Detection in Pleural Effusions as Diagnostic Biomarkers of Malignant Mesothelioma
por: Zallocco, Lorenzo, et al.
Publicado: (2022)

Increased Levels of C-C Chemokine RANTES in Asbestos Exposed Workers and in Malignant Mesothelioma Patients from an Hyperendemic Area
por: Comar, Manola, et al.
Publicado: (2014)

MSLN Gene Silencing Has an Anti-Malignant Effect on Cell Lines Overexpressing Mesothelin Deriving from Malignant Pleural Mesothelioma
por: Melaiu, Ombretta, et al.
Publicado: (2014)

Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma
por: Melaiu, Ombretta, et al.
Publicado: (2017)

Salivary psoriasin (S100A7) correlates with diffusion capacity of carbon monoxide in a large cohort of systemic sclerosis patients
por: Giusti, Laura, et al.
Publicado: (2016)

Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines
por: Melaiu, Ombretta, et al.
Publicado: (2017)

Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism
por: De Santi, Chiara, et al.
Publicado: (2017)

Bottom-up proteomics suggests an association between differential expression of mitochondrial proteins and chronic fatigue syndrome
por: Ciregia, F, et al.
Publicado: (2016)

New Insight into Benign Tumours of Major Salivary Glands by Proteomic Approach
por: Donadio, Elena, et al.
Publicado: (2013)

Preliminary update of the Mortality Probability Model (MPM0)
por: Higgins, T, et al.
Publicado: (2005)

Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes
por: Baldini, Chiara, et al.
Publicado: (2011)

A multidisciplinary approach to study a couple of monozygotic twins discordant for the chronic fatigue syndrome: a focus on potential salivary biomarkers
por: Ciregia, Federica, et al.
Publicado: (2013)

Antimeningococcal Vaccination Coverage Among Healthcare Workers in an Italian University Hospital
por: Gattini, Vittorio, et al.
Publicado: (2021)

Evaluation of formalin-fixed paraffin-embedded tissues in the proteomic analysis of parathyroid glands
por: Donadio, Elena, et al.
Publicado: (2011)

Correspondence between salivary proteomic pattern and clinical course in primary Sjögren syndrome and non-Hodgkin's lymphoma: a case report
por: Baldini, Chiara, et al.
Publicado: (2011)

Variation rs2235503 C > A Within the Promoter of MSLN Affects Transcriptional Rate of Mesothelin and Plasmatic Levels of the Soluble Mesothelin-Related Peptide
por: Silvestri, Roberto, et al.
Publicado: (2020)

Malignant Pleural Mesothelioma (MPM) Presenting as Hydropneumothorax
por: Kuramochi, Masami, et al.
Publicado: (2023)

Analisi dell’intervento per arresto cardiaco in casi occorsi in ambienti di lavoro nel territorio servito da una centrale operativa del 118 della Toscana
por: Marino, Riccardo, et al.
Publicado: (2020)

Big and Free Fractions of Gamma-Glutamyltransferase: New Diagnostic Biomarkers for Malignant Mesothelioma?
por: Foddis, Rudy, et al.
Publicado: (2022)

Proteomic Profiling Reveals Specific Molecular Hallmarks of the Pig Claustrum
por: Pirone, Andrea, et al.
Publicado: (2023)

Simplified approach to ICU severity scoring with MPM and EUROSCORE
por: Reeves, JH, et al.
Publicado: (2010)

Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM)
por: Klampatsa, Astero, et al.
Publicado: (2017)

Mortality probability model II (MPM(0–72)) in 1667 patients with acute cardiovascular disorders
por: Janssens, U, et al.
Publicado: (2002)

First evidence of TRPV5 and TRPV6 channels in human parathyroid glands: possible involvement in neoplastic transformation
por: Giusti, Laura, et al.
Publicado: (2014)

Palmitate-induced lipotoxicity alters acetylation of multiple proteins in clonal β cells and human pancreatic islets
por: Ciregia, Federica, et al.
Publicado: (2017)

Altered Protease–Activated Receptor-1 Expression and Signaling in a Malignant Pleural Mesothelioma Cell Line, NCI-H28, with Homozygous Deletion of the β-Catenin Gene
por: Fazzini, Alessandra, et al.
Publicado: (2014)

MA04.07 Clinical Characteristics and Outcomes in Patients With Malignant Pleural Mesothelioma (MPM) with COVID-19 Infection
por: Cedres, S., et al.
Publicado: (2021)

A Proteomic Approach to Uncover Neuroprotective Mechanisms of Oleocanthal against Oxidative Stress
por: Giusti, Laura, et al.
Publicado: (2018)

Heterogeneous Contributing Factors in MPM Disease Development and Progression: Biological Advances and Clinical Implications
por: Tolani, Bhairavi, et al.
Publicado: (2018)

MTA1 promotes metastasis of MPM via suppression of E-cadherin
por: Xu, Caihua, et al.
Publicado: (2015)

Immunomodulatory germline variation associated with the development of multiple primary melanoma (MPM)
por: Ferguson, Robert, et al.
Publicado: (2019)

Immunotherapy, the promise for present and future of malignant pleural mesothelioma (MPM) treatment
por: Gounant, Valérie, et al.
Publicado: (2021)

Predicting Mortality in Low-Income Country ICUs: The Rwanda Mortality Probability Model (R-MPM)
por: Riviello, Elisabeth D., et al.
Publicado: (2016)

Long Non Coding RNAs (lncRNAs) Are Dysregulated in Malignant Pleural Mesothelioma (MPM)
por: Wright, Casey M., et al.
Publicado: (2013)

Mutational Profile of Malignant Pleural Mesothelioma (MPM) in the Phase II RAMES Study
por: Pagano, Maria, et al.
Publicado: (2020)

Essential role of the histone lysine demethylase KDM4A in the biology of malignant pleural mesothelioma (MPM)
por: Lapidot, Moshe, et al.
Publicado: (2021)

Proteomic approach used in the diagnosis of Riedel's thyroiditis: a case report
por: Iacconi, Pietro, et al.
Publicado: (2012)

The Role of E-Cadherin and microRNA on FAK Inhibitor Response in Malignant Pleural Mesothelioma (MPM)
por: Yuen, Man Lee, et al.
Publicado: (2021)

At least two kinases phosphorylate the MPM-2 epitope during Xenopus oocyte maturation
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_v1702cddfjqe6n85iolnv9je6h